A citation-based method for searching scientific literature

Marianna Penzo, Lorenzo Montanaro, Davide Treré, Massimo Derenzini. Cells 2019
Times Cited: 94







List of co-cited articles
875 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ribosome biogenesis in cancer: new players and therapeutic avenues.
Joffrey Pelletier, George Thomas, Siniša Volarević. Nat Rev Cancer 2018
312
25

Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.
Denis Drygin, Amy Lin, Josh Bliesath, Caroline B Ho, Sean E O'Brien, Chris Proffitt, Mayuko Omori, Mustapha Haddach, Michael K Schwaebe, Adam Siddiqui-Jain,[...]. Cancer Res 2011
366
19

Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
Megan J Bywater, Gretchen Poortinga, Elaine Sanij, Nadine Hein, Abigail Peck, Carleen Cullinane, Meaghan Wall, Leonie Cluse, Denis Drygin, Kenna Anderes,[...]. Cancer Cell 2012
386
19

Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics.
Frédéric Catez, Nicole Dalla Venezia, Virginie Marcel, Christiane Zorbas, Denis L J Lafontaine, Jean-Jacques Diaz. Biochem Pharmacol 2019
67
22

MYC as a regulator of ribosome biogenesis and protein synthesis.
Jan van Riggelen, Alper Yetil, Dean W Felsher. Nat Rev Cancer 2010
559
13

Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging.
Zsofia Turi, Matthew Lacey, Martin Mistrik, Pavel Moudry. Aging (Albany NY) 2019
73
17

Ribosome biogenesis and cancer.
Massimo Derenzini, Lorenzo Montanaro, Davide Trerè. Acta Histochem 2017
70
17

Rare ribosomopathies: insights into mechanisms of cancer.
Anna Aspesi, Steven R Ellis. Nat Rev Cancer 2019
55
20

CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.
Hong Xu, Marco Di Antonio, Steven McKinney, Veena Mathew, Brandon Ho, Nigel J O'Neil, Nancy Dos Santos, Jennifer Silvester, Vivien Wei, Jessica Garcia,[...]. Nat Commun 2017
273
11

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study.
Amit Khot, Natalie Brajanovski, Donald P Cameron, Nadine Hein, Kylee H Maclachlan, Elaine Sanij, John Lim, John Soong, Emma Link, Piers Blombery,[...]. Cancer Discov 2019
80
13

Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age.
Rita Ferreira, John S Schneekloth, Konstantin I Panov, Katherine M Hannan, Ross D Hannan. Cells 2020
67
16

An overview of pre-ribosomal RNA processing in eukaryotes.
Anthony K Henras, Célia Plisson-Chastang, Marie-Françoise O'Donohue, Anirban Chakraborty, Pierre-Emmanuel Gleizes. Wiley Interdiscip Rev RNA 2015
341
10

Cancer Biogenesis in Ribosomopathies.
Sergey O Sulima, Kim R Kampen, Kim De Keersmaecker. Cells 2019
35
28

Chemotherapeutic drugs inhibit ribosome biogenesis at various levels.
Kaspar Burger, Bastian Mühl, Thomas Harasim, Michaela Rohrmoser, Anastassia Malamoussi, Mathias Orban, Markus Kellner, Anita Gruber-Eber, Elisabeth Kremmer, Michael Hölzel,[...]. J Biol Chem 2010
286
10

A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress.
Peter M Bruno, Yunpeng Liu, Ga Young Park, Junko Murai, Catherine E Koch, Timothy J Eisen, Justin R Pritchard, Yves Pommier, Stephen J Lippard, Michael T Hemann. Nat Med 2017
235
10

Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis.
Richard Y Ebright, Sooncheol Lee, Ben S Wittner, Kira L Niederhoffer, Benjamin T Nicholson, Aditya Bardia, Samuel Truesdell, Devon F Wiley, Benjamin Wesley, Selena Li,[...]. Science 2020
111
10


The nucleolus under stress.
Séverine Boulon, Belinda J Westman, Saskia Hutten, François-Michel Boisvert, Angus I Lamond. Mol Cell 2010
657
9

The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer.
Denis Drygin, William G Rice, Ingrid Grummt. Annu Rev Pharmacol Toxicol 2010
306
9


Hallmarks of ribosomopathies.
Kim R Kampen, Sergey O Sulima, Stijn Vereecke, Kim De Keersmaecker. Nucleic Acids Res 2020
64
14

Ribosomopathies: Old Concepts, New Controversies.
Katherine I Farley-Barnes, Lisa M Ogawa, Susan J Baserga. Trends Genet 2019
76
11

Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease.
Varsha Prakash, Brittany B Carson, Jennifer M Feenstra, Randall A Dass, Petra Sekyrova, Ayuko Hoshino, Julian Petersen, Yuan Guo, Matthew M Parks, Chad M Kurylo,[...]. Nat Commun 2019
81
11

Does the ribosome translate cancer?
Davide Ruggero, Pier Paolo Pandolfi. Nat Rev Cancer 2003
734
9

Eukaryotic Ribosome Assembly.
Jochen Baßler, Ed Hurt. Annu Rev Biochem 2019
159
8

c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription.
Azadeh Arabi, Siqin Wu, Karin Ridderstråle, Holger Bierhoff, Chiounan Shiue, Karoly Fatyol, Sara Fahlén, Per Hydbring, Ola Söderberg, Ingrid Grummt,[...]. Nat Cell Biol 2005
345
8

Inhibiting eukaryotic ribosome biogenesis.
Dominik Awad, Michael Prattes, Lisa Kofler, Ingrid Rössler, Mathias Loibl, Melanie Pertl, Gertrude Zisser, Heimo Wolinski, Brigitte Pertschy, Helmut Bergler. BMC Biol 2019
26
30

Ribosomal proteins: functions beyond the ribosome.
Xiang Zhou, Wen-Juan Liao, Jun-Ming Liao, Peng Liao, Hua Lu. J Mol Cell Biol 2015
348
8

Ribosomopathies: There's strength in numbers.
Eric W Mills, Rachel Green. Science 2017
223
8

A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.
Karita Peltonen, Laureen Colis, Hester Liu, Rishi Trivedi, Michael S Moubarek, Henna M Moore, Baoyan Bai, Michelle A Rudek, Charles J Bieberich, Marikki Laiho. Cancer Cell 2014
171
8

Nucleolar stress with and without p53.
Allison James, Yubo Wang, Himanshu Raje, Raphyel Rosby, Patrick DiMario. Nucleus 2014
173
7

Ribosomopathies: human disorders of ribosome dysfunction.
Anupama Narla, Benjamin L Ebert. Blood 2010
527
7

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

Nucleolus, ribosomes, and cancer.
Lorenzo Montanaro, Davide Treré, Massimo Derenzini. Am J Pathol 2008
306
7

c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I.
Carla Grandori, Natividad Gomez-Roman, Zoe A Felton-Edkins, Celine Ngouenet, Denise A Galloway, Robert N Eisenman, Robert J White. Nat Cell Biol 2005
470
7

The nucleolus: an emerging target for cancer therapy.
Nadine Hein, Katherine M Hannan, Amee J George, Elaine Sanij, Ross D Hannan. Trends Mol Med 2013
156
7

A new system for naming ribosomal proteins.
Nenad Ban, Roland Beckmann, Jamie H D Cate, Jonathan D Dinman, François Dragon, Steven R Ellis, Denis L J Lafontaine, Lasse Lindahl, Anders Liljas, Jeffrey M Lipton,[...]. Curr Opin Struct Biol 2014
368
7

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
7

p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer.
Virginie Marcel, Sandra E Ghayad, Stéphane Belin, Gabriel Therizols, Anne-Pierre Morel, Eduardo Solano-Gonzàlez, Julie A Vendrell, Sabine Hacot, Hichem C Mertani, Marie Alexandra Albaret,[...]. Cancer Cell 2013
184
7

Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.
Maria Barna, Aya Pusic, Ornella Zollo, Maria Costa, Nadya Kondrashov, Eduardo Rego, Pulivarthi H Rao, Davide Ruggero. Nature 2008
299
7

Eukaryotic ribosome biogenesis at a glance.
Emma Thomson, Sébastien Ferreira-Cerca, Ed Hurt. J Cell Sci 2013
181
7

Ribosomopathies: how a common root can cause a tree of pathologies.
Nadia Danilova, Hanna T Gazda. Dis Model Mech 2015
115
6

Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis.
Mikael S Lindström, Deana Jurada, Sladana Bursac, Ines Orsolic, Jiri Bartek, Sinisa Volarevic. Oncogene 2018
110
6

The economics of ribosome biosynthesis in yeast.
J R Warner. Trends Biochem Sci 1999
6

Signaling to p53: ribosomal proteins find their way.
Yanping Zhang, Hua Lu. Cancer Cell 2009
421
6

A Pan-cancer Analysis of the Expression and Clinical Relevance of Small Nucleolar RNAs in Human Cancer.
Jing Gong, Yajuan Li, Chun-Jie Liu, Yu Xiang, Chunlai Li, Youqiong Ye, Zhao Zhang, David H Hawke, Peter K Park, Lixia Diao,[...]. Cell Rep 2017
137
6

Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation.
Michael Hölzel, Michaela Rohrmoser, Martin Schlee, Thomas Grimm, Thomas Harasim, Anastassia Malamoussi, Anita Gruber-Eber, Elisabeth Kremmer, Wolfgang Hiddemann, Georg W Bornkamm,[...]. J Cell Biol 2005
144
6

2'-O-Methylation of Ribosomal RNA: Towards an Epitranscriptomic Control of Translation?
Piero Lo Monaco, Virginie Marcel, Jean-Jacques Diaz, Frédéric Catez. Biomolecules 2018
61
9

Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress.
Emilien Nicolas, Pascaline Parisot, Celina Pinto-Monteiro, Roxane de Walque, Christophe De Vleeschouwer, Denis L J Lafontaine. Nat Commun 2016
106
6

Ribosome biogenesis and cancer: basic and translational challenges.
Xosé R Bustelo, Mercedes Dosil. Curr Opin Genet Dev 2018
37
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.